By PPN News Staff
The FDA approved a new indication for cariprazine (Vraylar, Allergan) for the maintenance treatment of adults with schizophrenia.
Cariprazine is already approved in the United States in adults for the acute treatment of schizophrenia and acute treatment of manic episodes of bipolar I disorder.
“Schizophrenia is one of the most challenging mental health disorders to manage, particularly due to the complexity of patient symptoms, varying response to treatment and high